nach oben

Maternal and Child Health Journal

Erschienen in:

07.02.2018

Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure

Erschienen in: Maternal and Child Health Journal | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The prevalence of opioid use during pregnancy is increasing. Two downstream effects are neonatal abstinence syndrome (NAS), a postnatal withdrawal syndrome, and long-term prenatal opioid exposure (LTPOE) without documented withdrawal symptoms in the infant. Mental health characteristics of mothers of infants with NAS and LTPOE have not been described.

Methods

Using linked maternal and infant Medicaid claims and birth certificate data, we analyzed 15,571 infants born to Medicaid-insured women 15–24 years old in a mid-Atlantic city from 2007 to 2010. Pairwise comparisons with multinomial logistic regression, adjusting for maternal and infant covariates, were performed. We compared four mental health conditions among mothers of infants with NAS, infants with LTPOE without NAS, and controls: depression, anxiety, bipolar disorder, and schizophrenia.

Results

The prevalence of depression among mothers of infants with NAS, infants with LTPOE, and controls was 26, 21.1, and 5.5% respectively. Similar results were found for anxiety. In multivariable analysis, mothers of infants with NAS and LTPOE had approximately twice the depression risk as controls, while mothers of infants with LTPOE had 2.2 times the bipolar disorder risk and 4.6 times the schizophrenia risk as controls. The overall risk of mental health conditions in mothers of infants with NAS and LTPOE was similar.

Discussion

Mothers of infants with LTPOE who did not develop NAS are at similarly high risk for mental health conditions as mothers of infants with NAS, and both are at higher risk than controls. Therefore, those mothers of infants who did not develop symptoms of NAS despite LTPOE may be a vulnerable population that needs additional mental health support in the post-partum period.

Bateman, B. T., Hernandez-Diaz, S., Rathmell, J. P., et al. (2014). Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology, 120(5), 1216–1224. https://doi.org/10.1097/ALN.0000000000000172.CrossRefPubMedPubMedCentral

Burns, K., Melamed, J., Burns, W., Chasnoff, I., & Hatcher, R. (1985). Chemical dependence and clinical depression in pregnancy. Journal of Clinical Psychology, 41(6), 851–854.CrossRefPubMed

Cabrera, N. J., Ryan, R. M., Mitchell, S. J., Shannon, J. D., & Tamis-Lemonda, C. S. (2008). Low-income, nonresident father involvement with their toddlers: Variation by fathers’ race and ethnicity. Journal of Family Psychology, 22(4), 643–647. https://doi.org/10.1037/0893-3200.22.3.643. CrossRefPubMedPubMedCentral

Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002. https://doi.org/10.1097/AOG.0000000000000208.CrossRefPubMedPubMedCentral

Desai, R. J., Huybrechts, K. F., Hernandez-Diaz, S., et al. (2015). Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: Population based cohort study. BMJ, 350, h2102. https://doi.org/10.1136/bmj.h2102.CrossRefPubMedPubMedCentral

Dryden, C., Young, D., Hepburn, M., & MacTier, H. (2009). Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG: An International Journal of Obstetrics and Gynaecology, 116(5), 665–671. https://doi.org/10.1111/j.1471-0528.2008.02073.x.CrossRef

Epstein, R. A., Bobo, W. V., Martin, P. R., et al. (2013). Increasing pregnancy-related use of prescribed opioid analgesics. Annals of Epidemiology, 23(8), 498–503. https://doi.org/10.1016/j.annepidem.2013.05.017.CrossRefPubMedPubMedCentral

Fitzsimons, H. E., Tuten, M., Vaidya, V., & Jones, H. E. (2007). Mood disorders affect drug treatment success of drug-dependent pregnant women. Journal of Substance Abuse Treatment, 32(1), 19–25. https://doi.org/10.1016/j.jsat.2006.06.015.CrossRefPubMed

Haller, D. L., Knisely, J. S., Dawson, K. S., & Schnoll, S. H. (1993). Perinatal substance abusers. Psychological and social characteristics. Journal of Nervous and Mental Disease, 181(8), 509–513. https://doi.org/10.1097/00005053-199308000-00006.CrossRefPubMed

Holbrook, A., & Kaltenbach, K. (2012). Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. American Journal of Drug and Alcohol Abuse, 38(6), 575–579. https://doi.org/10.3109/00952990.2012.696168.CrossRefPubMed

Hudak, M. L., & Tan, R. C. (2012). Neonatal Drug Withdrawal. Pediatrics, 129, e540–e560. https://doi.org/10.1542/peds.2011-3212.CrossRefPubMed

Jones, H. E., Deppen, K., Hudak, M. L., et al. (2014). Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers. American Journal of Obstetrics and Gynecology, 210, 302–310. https://doi.org/10.1016/j.ajog.2013.10.010.CrossRefPubMed

Kelly, J. J., Davis, P. G., & Henschke, P. N. (2000). The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre. Journal of Paediatrics and Child Health, 36, 262–264. https://doi.org/10.1046/j.1440-1754.2000.00492.x.CrossRefPubMed

Kelly, L. E., Rieder, M. J., Bridgman-Acker, K., Lauwers, A., Madadi, P., & Koren, G. (2012). Are infants exposed to methadone in utero at an increased risk for mortality? Journal of Population Therapeutics and Clinical Pharmacology, 19, 160–165.

Kern, J. K., West, E. Y., Grannemann, B. D., et al. (2004). Reductions in stress and depressive symptoms in mothers of substance-exposed infants, participating in a psychosocial program. Maternal and Child Health Journal, 8, 127–136. https://doi.org/10.1023/B:MACI.0000037646.01017.b9.CrossRefPubMed

Kissin, W. B., Svikis, D. S., Morgan, G. D., & Haug, N. A. (2001). Characterizing pregnant drug-dependent women in treatment and their children. Journal of Substance Abuse Treatment, 21(1), 27–34. https://doi.org/10.1016/S0740-5472(01)00176-3.CrossRefPubMed

Kocherlakota, P. (2014). Neonatal abstinence syndrome. Pediatrics, 134(2), e547-61. https://doi.org/10.1542/peds.2013-3524.CrossRefPubMed

Krans, E., & Patrick, S. (2016). Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics and Gynecology, 128(1), 4–10. https://doi.org/10.1097/AOG.0000000000001446.CrossRefPubMedPubMedCentral

Lean, R. E., Pritchard, V. E., & Woodward, L. J. (2013). Child protection and out-of-home placement experiences of preschool children born to mothers enrolled in methadone maintenance treatment during pregnancy. Children and Youth Services Review, 35(11), 1878–1885. https://doi.org/10.1016/j.childyouth.2013.09.003.CrossRef

Logan, B., Brown, M. S., & Hayes, M. J. (2013). Neonatal abstinence syndrome: treatment and pediatric outcomes. Clinical Obstetrics and Gynecology, 56, 186–192. https://doi.org/10.1097/GRF.0b013e31827feea4.CrossRefPubMedPubMedCentral

Matone, M., Minkovitz, C., Quarshie, W., & Rubin, D. M. (2016). Chronic disease prevalence and discontinuation of medications among young mothers with a relationship to the child welfare system. Children and Youth Services Review, 64, 66–72. https://doi.org/10.1016/j.childyouth.2016.02.017.CrossRef

Parker, J. D., & Schoendorf, K. C. (2002). Implications of cleaning gestational age data. Paediatric and Perinatal Epidemiology, 16(2), 181–187. https://doi.org/10.1046/j.1365-3016.2002.00407.x.CrossRefPubMed

Patrick, S. W., Davis, M. M., Lehman, C. U., & Cooper, W. O. (2015b). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012 HHS Public Access. Journal of Perinatology, 35(8), 650–655. https://doi.org/10.1038/jp.2015.36.CrossRefPubMedPubMedCentral

Patrick, S. W., Dudley, J., Martin, P. R., et al. (2015a). Prescription opioid epidemic and infant outcomes. Pediatrics, 135(5), 842–850. https://doi.org/10.1542/peds.2014-3299.CrossRefPubMedPubMedCentral

Patrick, S. W., Kaplan, H. C., Passarella, M., Davis, M. M., & Lorch, S. A. (2014). Variation in treatment of neonatal abstinence syndrome in US Children’s Hospitals, 2004–2011. Journal of Perinatology, 34(11), 867–872. https://doi.org/10.1038/jp.2014.114.

Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA, 307(18), 1934–1940. https://doi.org/10.1001/jama.2012.3951.CrossRefPubMed

Pearson, R. M., Evans, J., Kounali, D., et al. (2013). Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry, 70(12), 1312–1319. https://doi.org/10.1001/jamapsychiatry.2013.2163.CrossRefPubMedPubMedCentral

Phibbs, C. S., Baker, L. C., Caughey, A. B., Danielsen, B., Schmitt, S. K., & Phibbs, R. H. (2007). Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. The New England Journal of Medicine, 356, 2165–2175. https://doi.org/10.1056/NEJMsa065029.CrossRefPubMed

Siu, A. L., & the U. S. Preventive Services Task Force (USPSTF). (2016). Screening for depression in adults: US preventive services task force recommendation statement. JAMA, 315(4), 380–387. https://doi.org/10.1001/jama.2015.18392.CrossRefPubMed

Smith, M. V., Costello, D., & Yonkers, K. A. (2015). Clinical correlates of prescription opioid analgesic use in pregnancy. Maternal and Child Health Journal, 19(3), 548–556. https://doi.org/10.1007/s10995-014-1536-6.CrossRefPubMedPubMedCentral

Tolia, V. N., Patrick, S. W., Bennett, M. M., et al. (2015). Increasing incidence of the neonatal abstinence syndrome in U.S. Nnonatal ICUs. The New England Journal of Medicine, 372(22), 2118–2126. https://doi.org/10.1056/NEJMsa1500439.

Tronick, E., & Reck, C. (2009). Infants of depressed mothers. Harvard Review of Psychiatry, 17, 147–156. https://doi.org/10.1017/S0954579400005551.CrossRefPubMed

Uebel, H., Wright, I. M., Burns, L., et al. (2015). Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics, 136(4), e811-e820. https://doi.org/10.1542/peds.2014-2767.CrossRef

Unger, A., Jung, E., Winklbaur, B., & Fischer, G. (2010). Gender issues in the pharmacotherapy of opioid-addicted women: Buprenorphine. Journal of Addictive Diseases, 29(2), 217–230. https://doi.org/10.1080/10550881003684814.CrossRefPubMedPubMedCentral

Titel: Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure
Publikationsdatum: 07.02.2018
Erschienen in: Maternal and Child Health Journal / Ausgabe 6/2018
Print ISSN: 1092-7875
Elektronische ISSN: 1573-6628
DOI: https://doi.org/10.1007/s10995-018-2457-6

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure

Abstract

Background

Methods

Results

Discussion

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Prenatal Maternal Depressive Symptoms Predict Early Infant Health Concerns

Relationship Between Postpartum Depression and Psychological and Biological Variables in the Initial Postpartum Period

A Qualitative Exploration of Co-location as an Intervention to Strengthen Home Visiting Implementation in Addressing Maternal Child Health

Chlamydia trachomatis and Adverse Pregnancy Outcomes: Meta-analysis of Patients With and Without Infection

One Year Follow-up of Outcomes from the Randomized Clinical Trial of the Building on Family Strengths Program

Motivating Smoking Cessation Text Messages: Perspectives from Pregnant Smokers